First Manhattan CO Agenus Inc Transaction History

First Manhattan CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $1,300 - $2,640	-1,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $6.08 Million - $13 Million	-2,375,393 Reduced 99.96%	1,000 $5,000
Q1 2021 May 14, 2021	BUY	$2.69 - $5.25 $269 - $525	100 Added 0.0%	2,376,393 $6.46 Million
Q4 2020 Feb 16, 2021	BUY	$3.17 - $4.49 $3.12 Million - $4.42 Million	985,193 Added 70.82%	2,376,293 $7.56 Million
Q3 2020 Nov 12, 2020	BUY	$2.98 - $5.2 $1.18 Million - $2.06 Million	397,000 Added 39.94%	1,391,100 $5.56 Million
Q2 2020 Aug 14, 2020	BUY	$2.29 - $4.24 $2.28 Million - $4.21 Million	994,100 New	994,100 $3.91 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.